QT
Qi Tatarata
Credentials: ·
History
Research
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Nature Medicine · 2018 · 800 citations
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Nature Medicine · 2019 · 562 citations
Nature Medicine · 2020 · 536 citations

27 papers

11 papers

8 papers
- AC
6 papers

6 papers

4 papers

4 papers

4 papers



